Nexgel (NXGL) Research & Development (2021 - 2026)
Nexgel (NXGL) recorded Research & Development of $20,000 in Q2 2026.
Powered by 
Analysis
Nexgel (NXGL) Research & Development (2021 - 2026) Analysis & Trends
On a TTM basis, Nexgel's Research & Development came in at $21,000 as of Jun 30, 2026; for FY2025, it was $2,000, down 97.4% from FY2024.
- Annual Research & Development has declined for three straight years, with a four-year compound annual growth rate of -49.6% (FY2021 to FY2025).
- Across earlier years, Research & Development came in at $78,000 in FY2024 (-24.3%), $103,000 in FY2023 (-71.9%), $367,000 in FY2022 and $31,000 in FY2021.
- The Q2 2026 figure is the highest quarterly Research & Development since Q2 2024.
- Peak year-over-year performance for Research & Development in the last five years was growth of 242.9% in Q1 2022, against a decline of 96.9% in Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.30 Bn | 36.13 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.36 Bn | 15.43 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 14.14 Bn | 13.38 Bn | 363.37 Mn | - |
| 4 | Icon | 13.04 Bn | 10.15 Bn | 479.29 Mn | - |
| 5 | Fortrea Holdings | 1.88 Bn | 1.26 Bn | 139.20 Mn | - |
| 6 | Ginkgo Bioworks Holdings | 762.62 Mn | 537,907.95 | 18.44 Mn | 46.21 Mn |
| 7 | Evotec SE | 583.11 Mn | -990.11 Mn | - | - |
| 8 | Champions Oncology | 68.48 Mn | 44.13 Mn | 7.70 Mn | 2.34 Mn |
| 9 | MindWalk Holdings | 64.46 Mn | 28.68 Mn | 1.61 Mn | 921,603.43 |
| 10 | Nexgel | 1.75 Mn | -2.16 Mn | 1.11 Mn | 20,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20,000.00 |
| Dec 31, 2025 | -6,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Jun 30, 2024 | 76,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 55,000.00 |
| Mar 31, 2023 | 29,000.00 |
| Dec 31, 2022 | 39,000.00 |
| Sep 30, 2022 | 193,000.00 |
| Jun 30, 2022 | 111,000.00 |
| Mar 31, 2022 | 24,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Mar 31, 2021 | 7,000.00 |
API Access
Nexgel Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NXGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NXGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NXGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();